DK478287A - Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden - Google Patents

Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden

Info

Publication number
DK478287A
DK478287A DK478287A DK478287A DK478287A DK 478287 A DK478287 A DK 478287A DK 478287 A DK478287 A DK 478287A DK 478287 A DK478287 A DK 478287A DK 478287 A DK478287 A DK 478287A
Authority
DK
Denmark
Prior art keywords
procedure
erythropoietin
exercise
preparing
cell
Prior art date
Application number
DK478287A
Other languages
English (en)
Other versions
DK478287D0 (da
Inventor
Anton K Beck
Raymond M Withy
James R Zabrecky
Nicholas C Masiello
Original Assignee
Integrated Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrated Genetics Inc filed Critical Integrated Genetics Inc
Publication of DK478287D0 publication Critical patent/DK478287D0/da
Publication of DK478287A publication Critical patent/DK478287A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK478287A 1986-09-15 1987-09-14 Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden DK478287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/907,369 US4954437A (en) 1986-09-15 1986-09-15 Cell encoding recombinant human erythropoietin

Publications (2)

Publication Number Publication Date
DK478287D0 DK478287D0 (da) 1987-09-14
DK478287A true DK478287A (da) 1988-03-16

Family

ID=25423973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK478287A DK478287A (da) 1986-09-15 1987-09-14 Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden

Country Status (6)

Country Link
US (1) US4954437A (da)
EP (1) EP0267678A1 (da)
JP (1) JPS63185396A (da)
DK (1) DK478287A (da)
FI (1) FI873897A7 (da)
PT (1) PT85699B (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU646822B2 (en) * 1989-10-13 1994-03-10 Kirin-Amgen Inc. Erythropoietin isoforms
US5856298A (en) * 1989-10-13 1999-01-05 Amgen Inc. Erythropoietin isoforms
US7217689B1 (en) 1989-10-13 2007-05-15 Amgen Inc. Glycosylation analogs of erythropoietin
DE69233109T2 (de) * 1992-01-07 2004-05-19 Elan Pharmaceuticals, Inc., San Francisco Transgene tiermodelle fur alzheimer-krankheit
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6153407A (en) * 1992-07-28 2000-11-28 Beth Israel Deaconess Medical Center Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
US5614184A (en) * 1992-07-28 1997-03-25 New England Deaconess Hospital Recombinant human erythropoietin mutants and therapeutic methods employing them
IL110669A (en) * 1993-08-17 2008-11-26 Kirin Amgen Inc Erythropoietin analogs
US5459031A (en) * 1993-11-05 1995-10-17 Amgen Inc. Methods for controlling sialic acid derivatives in recombinant glycoproteins
US5919758A (en) * 1994-03-22 1999-07-06 Beth Israel Deaconess Medical Center Modified polypeptides with altered biological activity
US5888774A (en) * 1994-12-19 1999-03-30 Cangene Corporation Recombinant DNA molecules and expression vectors for erythropoietin
GB9506051D0 (en) * 1995-03-24 1995-05-10 Univ Singapore Gene expression
IL118201A (en) * 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
US6717031B2 (en) 1995-06-07 2004-04-06 Kate Dora Games Method for selecting a transgenic mouse model of alzheimer's disease
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
US6573055B2 (en) * 1997-04-21 2003-06-03 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids
US6187564B1 (en) 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
KR100622203B1 (ko) 1997-07-23 2006-09-07 로셰 디아그노스틱스 게엠베하 내인성 유전자 활성화에 의해 사람 단백질을 생성시키는 사람 세포주를 확인하는 방법
US6548296B1 (en) 1997-07-23 2003-04-15 Roche Diagnostics Gmbh Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
ES2273434T3 (es) * 1997-07-23 2007-05-01 Roche Diagnostics Gmbh Obtencion de la eritropoyetina mediante activacion genica endogena.
US6391633B1 (en) 1997-07-23 2002-05-21 Roche Diagnostics Gmbh Production of erythropoietin by endogenous gene activation
BR9811542A (pt) * 1997-07-23 2000-08-22 Roche Diagnostics Gmbh Identificação de linhas de células humanas para a produção de proteìnas humanas mediante ativação de genes endógena
ES2208798T3 (es) * 1997-09-01 2004-06-16 Aventis Pharma Deutschland Gmbh Eritropoyetina humana recombinante con un perfil de glicosilacion ventajoso.
AU744086B2 (en) * 1997-12-03 2002-02-14 Roche Diagnostics Gmbh Erythropoietin with high specific activity
RU2125093C1 (ru) * 1998-02-12 1999-01-20 Государственный научно-исследовательский институт особо чистых биопрепаратов Способ получения рекомбинантного человеческого эритропоэтина, штамм культивируемых клеток яичника китайского хомяка - продуцент эритропоэтина
DE69935345T3 (de) * 1998-10-23 2018-03-01 Amgen Inc. Methoden und zusammensetzungen zur prävention und behandlung der anämie
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
PE20010288A1 (es) 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
AU2001296354A1 (en) 2000-09-25 2002-04-02 Baylor College Of Medicine Improved system for regulation of transgene expression
AU3323002A (en) 2000-12-20 2002-07-01 Hoffmann La Roche Erythropoietin conjugates
RU2005106841A (ru) * 2002-08-09 2005-10-27 Мерк Патент ГмбХ (DE) Эпитопы т-клеток в эритропоэтине
ES2346226T3 (es) 2003-12-30 2010-10-13 Augustinus Bader Uso de la eritropoyetina para la regeneracion de tejido hepatico.
DE102004027816A1 (de) * 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
CN101062407A (zh) 2006-04-29 2007-10-31 中国科学院上海生命科学研究院 促红细胞生成素在预防或治疗视网膜损伤中的用途
CN101534847A (zh) 2006-08-04 2009-09-16 普罗龙药品公司 修饰型促红细胞生成素
JP2010504909A (ja) 2006-09-14 2010-02-18 メドジェニクス・メディカル・イスラエル・リミテッド 長期持続性の医薬製剤
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
JP5065391B2 (ja) * 2006-12-06 2012-10-31 日本ケミカルリサーチ株式会社 ヒトエリスロポエチンの製造方法
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
DE102008002209A1 (de) 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
KR101038532B1 (ko) * 2008-07-02 2011-06-02 학교법인 선목학원 인간 적혈구생성촉진인자(ｈＥＰＯ) 유전자를 내장하는레트로바이러스 발현벡터 및 이에 의해 형질전환된동물세포 및 가금
CA2736141C (en) 2008-09-23 2018-03-20 F. Hoffmann-La Roche Ag Purification of erythropoietin
DE102008054716A1 (de) 2008-12-16 2010-06-17 Evonik Degussa Gmbh Inprozesskontrolle in einem Verfahren zur Herstellung von EPO
SI3988660T1 (sl) 2009-05-02 2025-09-30 Genzyme Corporation Genska terapija za nevrodegenerativne motnje
KR20120117728A (ko) 2009-09-23 2012-10-24 바이오제너릭스 에이지 재조합 인간 에리트로포이에틴(ｅｐｏ)의 정제 방법, 이렇게 정제된 ｅｐｏ 및 이를 포함하는 약학적 조성물
AU2011268458B2 (en) 2010-06-15 2014-06-12 Medgenics Medical Israel Ltd. Long lasting drug formulations
CN103205478B (zh) * 2013-04-03 2014-03-05 北京四环生物制药有限公司 一种重组人促红素的工业化生产方法
WO2022159414A1 (en) 2021-01-22 2022-07-28 University Of Rochester Erythropoietin for gastroinfestinal dysfunction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
IL77081A (en) * 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
EP0236059B1 (en) * 1986-02-27 1994-04-27 Snow Brand Milk Products Co. Ltd. Preparation of erythropoietin-producing cells and production process of erythropoietin using same

Also Published As

Publication number Publication date
EP0267678A1 (en) 1988-05-18
FI873897L (fi) 1988-03-16
FI873897A7 (fi) 1988-03-16
PT85699B (pt) 1990-08-31
FI873897A0 (fi) 1987-09-09
JPS63185396A (ja) 1988-07-30
US4954437A (en) 1990-09-04
PT85699A (en) 1987-10-01
AU604051B2 (en) 1990-12-06
DK478287D0 (da) 1987-09-14
AU7842987A (en) 1989-03-16

Similar Documents

Publication Publication Date Title
DK478287D0 (da) Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden
DK437883A (da) Vandige mikroemulsioner, deres fremstilling og anvendelse
DK46181A (da) Fremgangsmaade til fremsilling af pyranoner og mellemprodukter til brug ved udoevelse af fremgangsmaaden
DK160768C (da) Fremgangsmaade til fremstilling af epoxidpolyaddukter og haerdemiddel til brug ved udfoerelse af fremgangsmaaden
DK512286A (da) Fremgangsmaade til fremstilling af peptider og middel til brug ved fremgangsmaaden
DK166433C (da) Apparat til brug ved optraening af mavemusklerne
DK266387D0 (da) Fremgangsmaade til fremstilling af pindeunderstoettede produkter, isaer spiseis, form til brug ved udoevelse af fremgangsmaaden og pindeunderstoettede produkter opnaaet ved udoevelse af fremgangsmaaden
DK328387D0 (da) Fremgangsmaade til genetisk modificering af gaer og 2-my-m plasmid-vektor til anvendelse ved fremgangsmaaden
DK521989A (da) Fremgangsmaade til dyrkning af celler og materialer til brug derved
DK163517C (da) Fremgangsmaade til fremstilling af 4'-epidaunorubicin og 3',4'-diepidaunorubicin
DK457581A (da) 4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
DK310179A (da) Fremgangsmaade til dyrkning af svampe og apparat til brug ved udoevelse af fremgangsmaaden
DK165922C (da) 1,2,3,6-tetrahydro-5-nitro-pyrimidinderivater, fremgangsmaade til deres fremstilling og deres anvendelse til bekaempelse af skadelige organismer
DK76890A (da) Cyclopropanderivater til brug ved fremstilling af cyclopropansyrederivater med dihalogenvinylkaede og med cis-struktur samt fremgangsmaade til fremstilling af cyclopropanderivaterne
NO820213L (no) Kjemiske forbindelser, deres fremstilling og deres anvendelse i legemidler
DK228386A (da) Praeparat og fremgangsmaade til paavisning af urease og anordning til brug ved fremgangsmaaden
DK145485D0 (da) Fremgangsmaade til fremstilling af pyrrolidon-derivater og mellemprodukter til brug ved udoevelse af fremgangsmaaden
DK467780A (da) Fremgangsmaade til fremstilling af 24,24-difluor25-hydrochlecalciferol og mellemprodukter til brug ved fremgangsmaaden
DK306184D0 (da) Guaninforbindelse, fremgangsmaade til fremstilling deraf og mellemprodukt til brug ved udoevelse af fremgangsmaaden
NO860475L (no) Elektrokjemisk celle og fremgangsmaate for fremstilling derav.
DK382286D0 (da) Elektrokemisk celle og fremgangsmaade til fremstilling af samme
NO864201L (no) Hoeyeenergimaterialer og fremgangsmaate for deres fremstilling.
DK157935C (da) Acetoacetylaminophenyl-disazo-diphenylpigmenter, deres fremstilling og anvendelse
DK36479A (da) 2,6-dinitrobenzenaminer deres fremstilling og anvendelse
NO790819L (no) Fremgangsmaate ved elektrolytisk halogen-alkalifremstilling og elektrolysecelle for utfoerelse av fremgangsmaaten

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment